Main Article Content
Objective: The Covid-19 pandemic which arose from Wuhan city in December 2019 led to some changes in the treatment and follow-up of orthopedic patients to protect both the patients and the health workers and their relatives from the contagion. Long-term settings for the sake of patients and health workers have been made to decrease the viral load and the Covid-19 transmission risk. The specialist opinions and the data coming from Italy and Spain where the pandemic affected earlier than most countries facilitated the necessary steps to take in oncologic orthopedics. These steps in general, it should be limited to acute cases such as pathological fractures and malignant tumors. During the acute phase of the pandemic; it requires postponement of all other oncological orthopedic cases and outpatient controls. All surgeries where delaying 3 months will not be a big problem in the long term should be kept waiting.
2. Wuhan coronavirus pandemic. Accessed 2020 21 april https://www.worldometers.info/coronavirus/
3. Chang Liang Z, Wang W, Murphy D, PoHui JH: Novel Coronavirus and Orthopaedic Surgery: Early Experiences from Singapore. J Bone Joint Surg Am 2020;00:745-749.
4. Massey, P. A., McClary, K., Zhang, A. S., Savoie, F. H., & Barton, R. S. (2020). Orthopaedic Surgical Selection and Inpatient Paradigms During the Coronavirus COVID-19 Pandemic. JAAOS-Journal of the American Academy of Orthopaedic Surgeons.
5. Casali, P. G., Bielack, S., Abecassis, N., Aro, H. T., Bauer, S., Biagini, R., ... &Brodowicz, T. (2018). Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 29(Supplement_4), iv79-iv95.
6. Kasper, B., Baumgarten, C., Garcia, J., Bonvalot, S., Haas, R., Haller, F., ... &Gronchi, A. (2017). An update on the management of sporadic desmoid-type fibromatosis: a European consensus initiative between Sarcoma PAtientsEuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG). Annals of Oncology, 28(10), 2399-2408.